Announced
Completed
Financials
Tags
biochemicals
Italy
Private
Cross Border
Acquisition
Venture Capital
Friendly
Single Bidder
sustainable chemicals
Minority
Specialty Chemicals
Completed
Private Equity
Synopsis
Sofinnova Partners, a European venture capital firm in life sciences, specializing in healthcare and sustainability, led a €15m Series A in GFBiochemicals, a sustainable chemical company, with participation from Sparta Capital. "GFBiochemicals is tackling one of the planet's most pressing and yet unrecognised challenges: how we make chemicals sustainable and non-harmful. Too many of our products are made with non-biodegradable, toxic chemicals, which cause environmental damage and affect people in their everyday life. Today's most successful and sustainable companies across all industries provide solutions which not only protect the environment but also deliver the best product. We believe you cannot compromise on the planet and you should not compromise on performance. We hope to inspire and support others to accelerate their transition to green chemistry," Mathieu Flamini, GFBiochemicals CEO.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.